These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19502261)

  • 41. The role of the endothelium in the short-term complications of hematopoietic SCT.
    Carreras E; Diaz-Ricart M
    Bone Marrow Transplant; 2011 Dec; 46(12):1495-502. PubMed ID: 21460864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Platelets and the antiphospholipid syndrome.
    Urbanus RT; Derksen RH; de Groot PG
    Lupus; 2008 Oct; 17(10):888-94. PubMed ID: 18827053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modulating thrombotic diathesis in hereditary thrombophilia and antiphospholipid antibody syndrome: a role for circulating microparticles?
    Campello E; Radu CM; Spiezia L; Simioni P
    Clin Chem Lab Med; 2017 Jun; 55(7):934-943. PubMed ID: 27816948
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cell-derived microparticles: a new challenge in neuroscience.
    Doeuvre L; Plawinski L; Toti F; Anglés-Cano E
    J Neurochem; 2009 Jul; 110(2):457-68. PubMed ID: 19457085
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of zinc in thrombosis and pulmonary embolism in the course of antiphospholipid syndrome (APS)--short review.
    Tubek S; Grzanka P; Tubek I
    Biol Trace Elem Res; 2008 Jun; 122(3):193-6. PubMed ID: 18172583
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Flow cytometric detection of endothelial microparticles (EMP): effects of centrifugation and storage alter with the phenotype studied.
    van Ierssel SH; Van Craenenbroeck EM; Conraads VM; Van Tendeloo VF; Vrints CJ; Jorens PG; Hoymans VY
    Thromb Res; 2010 Apr; 125(4):332-9. PubMed ID: 20117824
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Venous thrombosis in the antiphospholipid syndrome.
    Farmer-Boatwright MK; Roubey RA
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiphosphatidylethanolamine antibodies and the antiphospholipid syndrome.
    Sanmarco M; Boffa MC
    Lupus; 2009 Sep; 18(10):920-3. PubMed ID: 19671793
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell-derived microparticles in haemostasis and vascular medicine.
    Burnier L; Fontana P; Kwak BR; Angelillo-Scherrer A
    Thromb Haemost; 2009 Mar; 101(3):439-51. PubMed ID: 19277403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential diagnosis of acute rejection and chronic cyclosporine nephropathy after rat renal transplantation by detection of endothelial microparticles (EMP).
    Cui J; Yang J; Cao W; Sun Y
    Med Hypotheses; 2010 Dec; 75(6):666-8. PubMed ID: 20832948
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differences in Endothelial Activation and Dysfunction Induced by Antiphospholipid Antibodies Among Groups of Patients With Thrombotic, Refractory, and Non-refractory Antiphospholipid Syndrome.
    Velásquez M; Peláez LF; Rojas M; Narváez-Sánchez R; Velásquez JA; Escudero C; San Martín S; Cadavid ÁP
    Front Physiol; 2021; 12():764702. PubMed ID: 34925061
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microparticles in health and disease.
    Enjeti AK; Lincz LF; Seldon M
    Semin Thromb Hemost; 2008 Oct; 34(7):683-91. PubMed ID: 19085769
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lipid peroxidation as risk factor for endothelial dysfunction in antiphospholipid syndrome patients.
    Stanisavljevic N; Stojanovich L; Marisavljevic D; Djokovic A; Dopsaj V; Kotur-Stevuljevic J; Martinovic J; Memon L; Radovanovic S; Todic B; Lisulov D
    Clin Rheumatol; 2016 Oct; 35(10):2485-93. PubMed ID: 27562033
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The immunology of atherothrombosis in the antiphospholipid syndrome: antigen presentation and lipid intracellular accumulation.
    Matsuura E; Kobayashi K; Matsunami Y; Lopez LR
    Autoimmun Rev; 2009 May; 8(6):500-5. PubMed ID: 19171205
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endothelial microparticles: a universal marker of vascular health?
    Shantsila E
    J Hum Hypertens; 2009 May; 23(5):359-61. PubMed ID: 19020535
    [No Abstract]   [Full Text] [Related]  

  • 56. [Endothelial dysfunction and circulating microparticles in patients with antiphospholipid antibodies].
    Alijotas-Reig J; Palacio-García C
    Med Clin (Barc); 2012 Feb; 138(3):134-5. PubMed ID: 21940006
    [No Abstract]   [Full Text] [Related]  

  • 57. The antiphospholipid syndrome and endothelial function.
    Blum A; Simsolo C
    Isr Med Assoc J; 2004 Sep; 6(9):556-8. PubMed ID: 15373316
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Laboratory diagnosis of the antiphospholipid syndrome: a plethora of obstacles to overcome.
    Devreese K; Hoylaerts MF
    Eur J Haematol; 2009 Jul; 83(1):1-16. PubMed ID: 19226362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Livedo, dementia, thrombocytopenia, and endotheliitis without antiphospholipid antibodies: seronegative antiphospholipid-like syndrome.
    Duval A; Darnige L; Glowacki F; Copin MC; Martin De Lassalle E; Delaporte E; Auxenfants E
    J Am Acad Dermatol; 2009 Dec; 61(6):1076-8. PubMed ID: 19646781
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-endothelial antibodies interfere in apoptotic cell clearance and promote thrombosis in patients with antiphospholipid syndrome.
    Graham A; Ford I; Morrison R; Barker RN; Greaves M; Erwig LP
    J Immunol; 2009 Feb; 182(3):1756-62. PubMed ID: 19155525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.